Trade ABT stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Abbott Laboratories (ABT) is trading at US$102.19, down 1.13% today as of Sep 11, 13:13 EDT. The company has a market capitalisation of US$201.83B. Over the past 52 weeks, ABT has traded between US$81.97 and US$137.49. On Syfe you can trade ABT with $0 commission and add it to your watchlist.
| Previous close | US$103.36 |
|---|---|
| Market cap | US$201.83B |
| P/E ratio | 17.36 |
| 52-week range | US$81.97 – US$137.49 |
| Dividend yield | 2.42% |
| Volume | 7.65M |
| Exchange | US |
Add to Watchlist
Set Price Alert
Abbott Laboratories
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. It operates through the following segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment focuses on branded generic pharmaceuticals that are manufactured worldwide and marketed and sold outside the United States, primarily in emerging markets. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, clinics, physicians' offices, retailers, government agencies, and alternative care testing sites. The Nutritional Products segment oversees the worldwide sale of pediatric and adult nutritional products. The Medical Devices segment offers a broad range of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, as well as diabetes care and continuous glucose monitoring products. It also provides neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.
Year: 1949
Abbott Laboratories (ABT) stock is trading at US$102.19, -1.13% from the previous close of US$103.36.
The market cap for Abbott Laboratories (ABT) stock is approximately US$201.83B.
The price-to-earnings ratio for Abbott Laboratories (ABT) is 17.36, based on the latest reported earnings.
The 52-week high for Abbott Laboratories (ABT) stock is US$137.49.
The 52-week low for Abbott Laboratories (ABT) stock is US$81.97.
Yes, Abbott Laboratories (ABT) pays a dividend. The trailing 12-month dividend yield is 2.42%.
Stay on top of ABT
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
